Large-scale testing (Phase 3)Study completedNCT02184611
What this trial is testing
A 24 Week Efficacy Study of Inhaled Umeclidinium (UMEC) in Patients of Chronic Obstructive Pulmonary Disease (COPD) Using a Novel Dry Powder Inhaler (NDPI)
Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 308